
Kardigan develops personalized cardiovascular medicines intended to move patients beyond symptom management toward functional cures. The company uses a proprietary Cardiac Intelligence R&D platform…

Kardigan develops personalized cardiovascular medicines intended to move patients beyond symptom management toward functional cures. The company uses a proprietary Cardiac Intelligence R&D platform…
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,500+
New This Week
About Us Kardigan is a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world.
It is Kardigan’s mission to develop multiple targeted treatments in parallel that bring people with cardiovascular diseases to the cures they deserve.
Led by Tassos Giannakakos, Jay Edelberg, M.D., Ph.D., and Bob McDowell, Ph.D., Kardigan’s co-founders have reunited after leading MyoKardia to discover and develop mavacamten, the first cardiac myosin inhibitor, resulting in an acquisition by Bristol Myers Squibb in 2020.
We have a cutting-edge discovery and translational research platform, a pipeline of late-stage candidates, and an industry-leading team that is driven to improve the lives of patients.
At Kardigan, we are motivated by our values which guide how we work, interact, and achieve our goals. Driven by patients and their families , we are deeply committed to improving the lives of patients and prioritizing their needs above all else. We believe in being authentic —leading with truth to bring out the best in others by creating an environment where every person knows they will be fully accepted. With an eagerness to learn , we encourage the highest levels of curiosity and are open to changing our minds. We are committed to winning as a team with urgency, excellence, and intention, and support each other no matter what role we play or where we sit. Lastly, we strive to enable the impossible because patients are counting on us. We are not afraid to take risks to unlock innovation and advance scientific discoveries.
These values are the foundation of our work, empowering us to make a real difference, every day.
Job Overview The Executive Director of Medical Affairs – Digital Innovation & HEOR will lead the strategy, development, and execution of digital and AI-enabled initiatives and HEOR across Medical Affairs for a biopharma company with integrated pharmaceutical and medical device solutions. This role is responsible for transforming how digital enabled data and data evidence partnerships with Prolaio are generated, analyzed, and applied through medical strategy and tactics. Additionally, this role will focus on developing the HEOR and Real World Evidence strategy across the clinical programs at Kardigan and integrated with Prolaio evidence generation capabilities and tactics.
Operating at the intersection of medicine, data science, health economics, and technology, this leader will serve as a key partner to Clinical Development (Kardigan & Prolaio), Data Science, Commercial, and IT functions to ensure digital/AI capabilities and HEOR evidence generation plans are scientifically rigorous, compliant, and aligned with medical and enterprise strategy.
Essential Duties And Responsibilities Digital & AI Strategy (Medical Affairs)
Medical Insights, HEOR/RWE & Evidence Enablement
Cross-Functional Collaboration
Team Leadership & Capability Building
External Engagement & Innovation Ecosystem
Required Qualifications and Preferred Skills
Preferred
Exact Compensation may vary based on skills, experience and location.
Pay range
$275,000 - $358,000 USD